Hebei Medical University Fourth Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Hebei Medical University Fourth Hospital
RECRUITINGPhase 2NCT04159142
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative...
This is a multi-center , open-lable clinical trial. Triple-negative breast cancer (TNBC) is a term applied to breast cancer cases that have \<1% expression of the estrogen...
Sponsor: Hebei Medical University Fourth HospitalEnrolling: 4141 location
Triple Negative Breast CancerNab-paclitaxel
RECRUITINGNCT06009705
Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer
This trial aims to assess efficacy and safety of toripalimab combined with radiotherapy and S-1 followed by adjuvant toripalimab maintenance therapy for older patients with stage...
Sponsor: Hebei Medical University Fourth HospitalEnrolling: 561 location
Esophageal Carcinoma
RECRUITINGPhase 2NCT03964753
Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
To verify the role of nab-paclitaxel in neoadjuvant therapy for esophageal squamous cell carcinoma, the investigators designed a prospective, randomized, controlled , multicente...
Sponsor: Hebei Medical University Fourth HospitalEnrolling: 2021 location
Esophageal Squamous Cell Carcinoma